Last updated on February 2018

Treatment for Eczema (commonly known as Atopic Dermatitis)


Brief description of study

A Prospective, vehicle-controlled, double blind, multicenter, randomized phase II study of B244 delivered as a topical spray to determine safety in subjects with mild to moderate atopic dermatitis.

Clinical Study Identifier: TX155618

Find a site near you

Start Over

DeNova Research

845 N. Michigan Ave., Suite 923 East Chicago, IL USA
  Connect »